Publications
Specialty
Search
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/08/2024
“IVUS is more accurate than angiography in measuring vessel dimensions. It facilitates achieving sufficient vessel lumen diameters and aids in evaluating the response of the target lesion to treatment,” said Young-Guk Ko, MD, the study’s lead author. “Despite the potential increase in procedural complexity, IVUS may benefit patients by enhancing treatment outcomes.”
Journal of Invasive Cardiology, CardioVascular
04/08/2024
The authors conducted a global, web-based, anonymous survey of interventional cardiology fellows and attendings to assess the knowledge and perceptions of interventional cardiologists regarding artificial intelligence use in interventional cardiology.
IO Learning
04/08/2024
At the 2024 SIR Annual Meeting, Steve Raman, MD, presented 5-year follow-up data from a trial evaluating the use of transurethral ultrasound ablation among patients with prostate cancer.
Gastroenterology
04/08/2024
In this video, Dr Yang explains the strategies for evaluating PERT effectiveness, emphasizing the importance of ongoing patient monitoring.
Oncology
04/08/2024
The FDA granted accelerated approval to trastuzumab deruxtecan for patients with unresectable or metastatic HER2-positive solid tumors who have received systemic treatment and have no alternative treatment options.
Gastroenterology
04/08/2024
Learn the essential steps for initiating PERT, ensuring seamless onboarding, and providing appropriate patient counseling.
Neurology
04/08/2024
Hospitalized older adults with at least 1 episode of delirium had triple the risk of an incident dementia diagnosis within 5 years of follow-up compared with those without a delirium diagnosis, according to a study published online in The BMJ.
Gastroenterology
04/08/2024
In this short video, you’ll learn more about PERT, how it works, and identifying the unmet needs of patients with exocrine pancreatic insufficiency (EPI) treated with PERT.
Vascular Disease Management
04/08/2024
Learn about the recently published safety and efficacy data of the Auryon Laser System.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/08/2024
"When compared to male patients, female patients often present with more advanced symptoms of heart valve disease, highlighting the importance of uncovering how we can best educate women on early warning signs and treatment options sooner," stated Roxana Mehran, MD.
Cath Lab Digest, Journal of Invasive Cardiology, Journal of Invasive Cardiology, Vascular Disease Management
04/08/2024
Long-term durability data showed clinically meaningful, safe and sustained blood pressure (BP) reductions (-23.2 mmHg in office systolic BP and -14.0 mmHg reductions in 24-hour ambulatory BP) in patients with uncontrolled hypertension.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/08/2024
Results of the HUDDLE study indicated that the prevalence of hypertension in the 498 screened participants was 83.8%, though only about half (46.5%) self-reported a history of hypertension.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/08/2024
A late-breaking clinical trial confirms routine use of Impella CP in patients who have had a heart attack with STEMI cardiogenic shock reduces 180-day mortality by 12.7%, compared to the control arm (45.8% vs. 58.5%, p=0.04).
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/08/2024
New data demonstrate the early addition of twice-yearly* Leqvio (inclisiran) to maximally tolerated statin therapy, prior to guideline-recommended ezetimibe, in a real-world setting significantly reduced low-density lipoprotein cholesterol (LDL-C) in patients with atherosclerotic cardiovascular disease (ASCVD), including those with a history of an ASCVD-related event, who could not reach their goal on statin therapy alone.(1)
Rheumatology & Arthritis
04/08/2024
In this podcast, Drs England and Smith discuss the key recommendations and how to implement exercise, rehabilitation, diet, and additional interventions as part of an integrative management approach for people with rheumatoid arthritis.
Journal of Clinical Pathways
04/08/2024
Erin Fox, PharmD, shares steps health care stakeholders can take to mitigate the impact of drug shortages on cancer care.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/07/2024
The KARDIA-2 study achieved its primary endpoint demonstrating clinically and statistically significant additive, placebo-adjusted reductions of up to 12.1 mmHg in 24-hour mean systolic blood pressure (SBP) measured by ambulatory blood pressure monitoring (ABPM) when zilebesiran was added to a thiazide-like diuretic, calcium channel blocker or angiotensin receptor blocker, measured independently at Month 3.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/07/2024
Withdrawing aspirin one month after percutaneous coronary intervention (PCI) in high-risk heart patients and keeping them on ticagrelor alone safely improves outcomes and reduces major bleeding by more than half when compared to patients taking aspirin and ticagrelor combined (also known as dual antiplatelet therapy or DAPT), which is the current standard of care.
Cath Lab Digest, Journal of Invasive Cardiology, Vascular Disease Management, CardioVascular
04/07/2024
The CERAB technique (covered endovascular reconstruction of the aortic bifurcation) in combination with the BeGraft aortic and two BeGraft peripheral stents provide a treatment option especially for high-risk patients for whom open surgery is unsuitable.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/07/2024
The one-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial in individuals with aortic stenosis (AS) with small aortic annuli (SAA) demonstrated noninferior clinical outcomes and superior valve performance as measured by bioprosthetic valve dysfunction performance for the Evolut™ TAVR platform compared to the SAPIEN™ platform.
Current Issue
September 2024
Volume
Issue
Enter Your E-mail
EMSWorld Newsletter
